Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 816

From birth to death, tech is stretching the boundaries of biology. In this episode of Posthuman, we explore the discoveries that could transform reproduction, healthcare and how we die.

Technology that once seemed like science fiction is rapidly becoming reality, transforming the very essence of our existence. In this four-part series, Emily Chang unravels the future of being human in an age of unprecedented innovation.

Watch more Posthuman with Emily Chang: • Posthuman with Emily Chang.

#Tech #Science #Posthuman.
——-
Like this video? Subscribe: https://www.youtube.com/Bloomberg?sub_…

Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptio…

Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.

Continue reading “How Tech Is Breaking the Rules of Biology | Posthuman with Emily Chang” | >

During an EEG test, technicians normally use rulers and pencils to mark up a person’s head before gluing electrodes across the scalp. These electrodes are then connected via long wires to a machine that records brain activity. Alternatively, a cap with electrodes can be directly placed on the head.

However, this whole process is time-consuming and inconvenient, say the developers of the new technology. It generally takes around one to two hours to set up an EEG test, said co-developer Nanshu Lu, a professor of engineering at the University of Texas at Austin. The electrodes then need to be monitored about every two hours because the glue that attaches them to the scalp dries up, she told Live Science in an email.

Read more | >

A new study from The Hospital for Sick Children (SickKids) and Institut Curie reveals how stem cells sense and respond to their environment, with implications for inflammatory bowel disease and colorectal cancer.

Stem cells constantly adapt to their environment to maintain organ and tissue health, informed by and physical forces. When they do not function as intended, stem cells can result in a number of health conditions including (IBD) and colorectal (bowel) cancer, where they continue to divide until a tumor forms.

Until now, how stem cells sense the physical forces around them has remained unclear, but novel findings published in Science led by Dr. Meryem Baghdadi, a former SickKids postdoctoral researcher, Dr. Tae-Hee Kim at SickKids and Dr. Danijela Vignjevic at Institut Curie, has revealed that stem cells depend on two , called PIEZO1 and PIEZO2, for their survival.

Read more | >

A cancer therapy that prompts the body’s immune defenses against viruses and bacteria to attack tumors can make patients more vulnerable to heart attack and stroke. A possible explanation for this side effect is that the treatment interferes with immune regulation in the heart’s largest blood vessels, a new study suggests.

Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the new work focused on a potent class of cancer-fighting drugs called . These medications work by blocking molecules embedded on the surface of cells—immune checkpoints—which normally serve as “brake pedals” that prevent excess immune activity, or inflammation. Some tumors are known to hijack these checkpoints to weaken the body’s defenses, so by blocking the checkpoints, the treatments enable the to kill .

However, this treatment type may also trigger damaging levels of inflammation in the heart, brain, stomach, and other organs, the researchers say. For example, past studies have shown that about 10% of those with atherosclerosis, the buildup of hardened fatty deposits (plaques) within artery walls, have a heart attack or stroke following . However, the specific mechanisms behind this issue had until now remained unclear.

Read more | >

Cure-Focused Diabetes Research — Michael Burton & Prof. Matthias von Herrath — Diabetes Research Institute Foundation.

Michael J. Burton is the CEO of the Diabetes Research Institute Foundation (https://diabetesresearch.org/), a philanthropic organization which funds the Diabetes Research Institute, one of the largest and most comprehensive research centers dedicated to curing diabetes.

A passionate nonprofit executive, Michael has more than 30 years of experience in leading high-impact philanthropic programs and cultivating strategic relationships to secure transformative funding. Prior to assuming the role of CEO at DRIF, Michael advanced the missions of some of the nation’s most dynamic and trusted institutions including Princeton University, The Pew Charitable Trusts and the American Association for Cancer Research (AACR).

Michael’s accomplished nonprofit career includes significant contributions in the advancement of cancer research and care, most recently as President and CEO of Gateway for Cancer Research, a Chicago-based nonprofit engaged in funding early phase clinical research, where he began his tenure as Chief Development Officer. Prior to that, Michael served as Chief Development Officer and Executive Director of the Foundation at the AACR, the nation’s oldest and largest organization dedicated to the prevention and cure of all cancers. Michael’s 15 years of experience in the oncology sector also includes leading the development program at Fox Chase Cancer Center as Senior Vice President and Chief Development Officer.

Before working in the field of oncology, Michael had a distinguished career in higher education, most notably at the University of Pennsylvania, where he served as Special Assistant to the President during the tenure of Judith Rodin, the first female president of an Ivy League institution; and at Temple University, where he held the title of Assistant Dean and lead the development program at the Fox School of Business. Before entering higher education, Michael served as Legislative and Press Assistant to the late Congressman Tom Lantos, the only survivor of the Holocaust ever elected to Congress.

Continue reading “Michael Burton & Prof. Matthias von Herrath — Diabetes Research Inst — Biologically Curing Diabetes” | >

Summary: Researchers identified specific plant compounds that provide antioxidant and neuroprotective effects, contributing to brain health beyond basic nutrition. By analyzing plant-based foods like lemon balm, sage, and elderberry, scientists linked compounds such as phenolics and terpenes to benefits like reducing oxidative stress and scavenging harmful reactive species.

Quercetin-rich foods, such as Queen Garnet plum and clove, showed strong potential to prevent neuron-like cell damage. This study sheds light on how plant-based diets and supplements could support brain health and manage neuroinflammation-related conditions.

Read more | >